Oral cancer (OC) is the predominant type originating in the head and neck region. The
incidence of OC is mostly associated with behavioral risk factors, including tobacco smoking …

The statin family of drugs are safe and effective therapeutic agents for the treatment of
arteriosclerotic cardiovascular disease (CVD). Due to a wide range of health benefits in …

Hypopharynx cancer has the worst prognosis of all head and neck squamous cell cancers.
Since the 1990s, a treatment shift has appeared from a total laryngectomy towards organ …

Oral squamous cell carcinoma represents the most aggressive and frequent form of head
and neck cancer. Due to drug resistance, the 5-year survival rate of patients with advanced …

Importance Squamous cell carcinoma of the lip (lip SCC) composes more than 25% of all
oral cancers. Most of the demographic and prognostic indicators for lip SCC are only …

Background Radiomics-based non-invasive biomarkers are promising to facilitate the
translation of therapeutically related molecular subtypes for treatment allocation of patients …

Head and neck carcinoma (HNC) is a heterogeneous disease encompassing a variety of
tumors according to the origin. Laryngeal cancer (LC) represents one of the most frequent …

BACKGROUND Circulating cell-free DNA methylation testing in blood has recently received
regulatory approval for screening of colorectal cancer. Its application in other clinical …

Immunotherapy shows promising results and revolutionizes treatment of oral squamous cell
carcinoma (OSCC). The immunologic microenvironment might have prognostic/predictive …

Oral cancer is the sixteenth most common cancer globally, with a relatively poor five-year
survival rate of 50%. Thus it is imperative to understand the biology of oral cancer and …